Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | MDK | P21741 | 4/20 | 0.39 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP2 | P42575 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.33 |
| ▸ | PDE6D | O43924 | 1/20 | 0.32 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.31 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.31 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.31 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.31 |
| ▸ | GIGYF2 | Q6Y7W6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12458604 | 1.00 | F2 (0.42) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL4732589 | 0.97 | F2 (0.42) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL12799315 | 0.97 | F2 (0.45) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL12799348 | 0.97 | F2 (0.45) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL12458605 | 0.97 | F2 (0.45) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL12799304 | 0.96 | F2 (0.40) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL12458597 | 0.94 | F2 (0.43) | F2MDKSETD7CASP3CASP1 | |
| SCHEMBL12458601 | 0.90 | F2 (0.43) | F2MDKSETD7PDE6DL3MBTL3 | |
| SCHEMBL12799295 | 0.88 | F2 (0.47) | F2 | |
| SCHEMBL12458583 | 0.88 | F2 (0.47) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120238512-A1 | ANTITHROMBOTIC DUAL INHIBITORS COMPRISING A BIOTIN RESIDUE | MSD OSS B.V. (NL) | 2012-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238512-A1 | ANTITHROMBOTIC DUAL INHIBITORS COMPRISING A BIOTIN RESIDUE | BRS3, SERPINC1, TBXA2R | F2 67/4885MDK 4805/4885SETD7 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.